HomeInsightsStock Comparison

Brawn Biotech Ltd vs Emcure Pharmaceuticals Ltd Stock Comparison

Brawn Biotech Ltd vs Emcure Pharmaceuticals Ltd Stock Comparison

Last Updated on: Jul 22, 2025

Key Highlights

  • The Latest Trading Price of Brawn Biotech Ltd is ₹ 18.26 as of 22 Jul 12:17.
  • The P/E Ratio of Brawn Biotech Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Emcure Pharmaceuticals Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Brawn Biotech Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Emcure Pharmaceuticals Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Brawn Biotech Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Emcure Pharmaceuticals Ltd for the Mar '25 is ₹ 2120 crore as compare to the Dec '24 revenue of ₹ 1959 crore. This represent the growth of 8.23%.
  • The ebitda of Brawn Biotech Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Emcure Pharmaceuticals Ltd for the Mar '25 is ₹ 396.48 crore as compare to the Dec '24 ebitda of ₹ 358.5 crore. This represent the growth of 10.59%.
  • The net profit of Brawn Biotech Ltd changed from ₹ -0.04 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Emcure Pharmaceuticals Ltd changed from ₹ 140.97 crore to ₹ 197.24 crore over 8 quarters. This represents a CAGR of 18.29% .
  • The Dividend Payout of Brawn Biotech Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Emcure Pharmaceuticals Ltd changed from 25.8 % on March 2020 to 22.53 % on March 2024 . This represents a CAGR of -2.67% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Brawn Biotech Ltd

  • Brawn Biotech Ltd was originally incorporated in the name of Brawn Pharmaceuticals Limited in November, 1985.
  • Thereafter, the name of the Company was changed from Brawn Pharmaceuticals Limited to Brawn Biotech Limited in November, 2010.
  • Brawn , with its inception barely 38 years back has today evolved into a fully integrated, healthcare group, marking its presence in India and across the globe. The Company possess product registration with major health and govt. institutions throughout India and worldwide.
  • Headed and represented by a team of skilled industry experts with impressive educational backgrounds and broad experience, the Company has spread its wings in expansion in the domestic as well as in the international markets beyond the existing horizon to stand among the leading Indian HealthCare products distribution Companies.

About Emcure Pharmaceuticals Ltd

  • Emcure Pharmaceuticals Limited was originally incorporated as Emcure Pharmaceuticals Private Limited', as a Private Company, pursuant to a Certificate of Incorporation dated April 16, 1981 issued by Registrar of Companies, Maharashtra at Bombay.
  • Subsequently, Company was converted into a Public Company and the name of Company was changed to Emcure Pharmaceuticals Limited', through a fresh Certificate of Incorporation issued by the RoC, Maharashtra in Pune on September 18, 2001. Emcure Pharmaceuticals an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
  • They are a research and development driven company with a differentiated product portfolio that includes orals, injectables and biotherapeutics, which has enabled to reach target markets across over 70 countries, with a strong presence in India, Europe and Canada.

Brawn Biotech Ltd News Hub

News

Brawn Biotech to table results

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 26 May 2025....

Read more

17 May 2025 14:36

News

Brawn Biotech to table results

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 12 February ...

Read more

05 Feb 2025 12:58

News

Brawn Biotech to conduct board meeting

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 14 November ...

Read more

11 Nov 2024 12:21

News

Brawn Biotech to conduct AGM

Brawn Biotech announced that the 39th Annual General Meeting (AGM) of the company will be ...

Read more

05 Sep 2024 15:14

News

Brawn Biotech to discuss results

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 14 August 20...

Read more

12 Aug 2024 14:29

News

Brawn Biotech to discuss results

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 29 May 2024 ...

Read more

28 May 2024 14:18

Emcure Pharmaceuticals Ltd News Hub

News

Emcure Pharmaceuticals signs exclusive agreement with Sanofi India

Emcure Pharmaceuticals (Emcure) and Sanofi India (SIL) today entered into an exclusive dis...

Read more

16 Jul 2025 17:38

News

Emcure Pharmaceuticals appoints President ' India Business

Emcure Pharmaceuticals has appointed R.S. Vasan as President ' India Business and Senior M...

Read more

14 Jul 2025 13:17

News

Emcure Pharma gains after Sanand facility gets zero observations from USFDA

The inspection conducted from 30 June 2025 to 08 July 2025 and concluded without issuance ...

Read more

10 Jul 2025 09:50

News

Board of Emcure Pharmaceuticals recommends final dividend

Emcure Pharmaceuticals announced that the Board of Directors of the Company at its meeting...

Read more

22 May 2025 18:02

News

Emcure Pharmaceuticals to announce Quarterly Result

Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 22 ...

Read more

14 May 2025 15:15

News

Emcure Pharma's pune facility receives VAI status from USFDA

The company received the Establishment Inspection Report (EIR) from the USFDA following an...

Read more

21 Apr 2025 11:09

SWOT Analysis Of Brawn Biotech Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Emcure Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Brawn Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Brawn Biotech Ltd and Emcure Pharmaceuticals Ltd

Which company has a larger market capitalization, Brawn Biotech Ltd or Emcure Pharmaceuticals Ltd?

Market cap of Brawn Biotech Ltd is 5 Cr while Market cap of Emcure Pharmaceuticals Ltd is 25,726 Cr

What are the key factors driving the stock performance of Brawn Biotech Ltd and Emcure Pharmaceuticals Ltd?

The stock performance of Brawn Biotech Ltd and Emcure Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Brawn Biotech Ltd and Emcure Pharmaceuticals Ltd?

As of July 22, 2025, the Brawn Biotech Ltd stock price is INR ₹19.0. On the other hand, Emcure Pharmaceuticals Ltd stock price is INR ₹1357.55.

How do dividend payouts of Brawn Biotech Ltd and Emcure Pharmaceuticals Ltd compare?

To compare the dividend payouts of Brawn Biotech Ltd and Emcure Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions